Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 18, Issue 7, Pages 731-745Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1517/14728222.2014.909807
Keywords
drug resistance; epithelial-to-mesenchymal transition; metastasis
Categories
Ask authors/readers for more resources
Introduction: The process of epithelial-to-mesenchymal transition (EMT) has long been advocated as a process during tumor progression and the acquisition of metastatic potential of human cancers. EMT has also been linked with resistance to cancer therapies. Areas covered: Basic research has provided evidence connecting EMT to increased invasion, angiogenesis and metastasis of cancer cells. A number of signaling pathways such as notch, wnt, hedgehog and PI3K-AKT, and various other individual factors therein, have been intricately connected to the onset of EMT. Here, we provide latest updates on the evidences that further highlight an association between various signaling pathways and EMT, with a focus on therapeutic targets that may have the potential to reverse EMT. Expert opinion: Our understanding of EMT and its underlying causes is rapidly evolving and a number of putative targets have been identified. It is crucial, now than ever before, to design novel translational and clinical studies for the benefit of advanced stage cancer patients with metastatic disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available